Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 August 2019 | Story Zama Feni | Photo Charl Devenish
3MT
From the left: University of the Free State (UFS) students, Chantelle van der Bijl (Master’s Category) and Keafon Jumbam (PhD Category) emerged victorious at the annual institutional Three-Minute Thesis (3MT) Competition held on Friday, 23 August 2019.

Two University of the Free State (UFS) students, Keafon Jumbam (PhD) and Chantelle van der Bijl (master’s), emerged victorious at the annual institutional Three-Minute Thesis (3MT) competition held on the Bloemfontein Campus on Friday, 23 August 2019.

The 3MT is a research-communication competition which was developed by the University of Queensland (UQ), whereby PhD students are given three minutes to present a compelling oration on their thesis and its significance. 

Winning students

Jumbam, who is a student in the Faculty of Natural and Agricultural Sciences, cleaned the table in the PhD category, which had six contestants from various faculties. She walked away with a cash prize of R14 000.
She presented a thesis titled: Social, ecological and personality factors influencing bat-eared fox foraging behaviour.
Asked about the secret to her victory, Jumbam said: “You must ensure that you publish your work, because that gives a person a competitive edge, globally.”
In the Master’s Category, Chantelle van der Bijl grabbed the first spot, beating four other contestants in this category, winning an amount of R10 000.  Her thesis title was: Doctor Mothers: Infant feeding intentions and behaviours.
“I am excited to have won this. I am very grateful for the support I got from my family and faculty staff,” said Van der Bijl.

Idea behind the 3MT

The 3MT challenges students to consolidate their ideas and research discoveries in order to be presented concisely to a non-specialist audience. The 3MT was designed to develop skills that will give students an important career advantage once they complete their studies. 
The competition was originally reserved for PhD students, but the UFS Postgraduate School decided to include master’s students so as to prepare them in case they wanted to do their PhDs after their studies. 
The UFS winner in the Master’s Category (Van der Bijl) will not represent the university in the national final 3MT competition on 25 October 2019, but the 1st runner-up in the PhD category (Lourens Strauss) – as per the rules of the competition.

Nothing but research for better future
Giving a word of encouragement to the contestants on the importance of research, the Senior Director for Research Development, Dr Glen Taylor, said: “When our generation of practitioners and leaders (students) engage in research with its deliberate process and requirements for critical thinking skills, they become better students and are best prepared for the challenges and opportunities of the future. Research is an opportunity to make a difference; it is open to everyone and thrives on a diversity of approaches and perspectives.”

Taylor said universities have to be vital sources of new knowledge and innovative thinking, providers of skilled personnel, attractors of international talent and business investment into a region, agents of social justice and mobility, and contributors to social and cultural vitality.


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept